|
|
Growth Disorders - Chemically induced
Research News and Information
Definition of 'Growth Disorders'Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Common names: Growth Disorders; Disorder, Growth; Growth Disorder |
Sunday, November 22, 2009
22 Sep 2009
Adipose tissue is one of the major sites for fatty acid synthesis and lipid storage. We generated adipose (fat)-specific ACC1 knockout (FACC1KO) mice using the aP2-Cre/loxP system. FACC1KO mice showed prenatal growth retardation; after weaning, ... Read more...
[Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment]
30 Mar 2009
Bone turnover rate during growth is extremely rapid. Bone growth is under the control of various hormonal environments. Long term administration of glucocorticoid in childhood induced not only osteoporosis but also growth failure via direct action ... Read more...
2 Dec 2008
The aryl hydrocarbon receptor (AhR) is required for the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and so the AhR of CRL:WI and CRL:WI(Han) rats was characterized. Western blot showed AhR proteins of approximately 110 and approximately ... Read more...
Latest indexed articles for 'Growth Disorders - Chemically induced'
These are the very latest articles for this heading:
- aP2-Cre-mediated inactivation of acetyl-CoA carboxylase 1 causes growth retardation and reduced lipid accumulation in adipose tissues.
22 Sep 2009 - [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment]
30 Mar 2009 - A truncation in the aryl hydrocarbon receptor of the CRL:WI(Han) rat does not affect the developmental toxicity of TCDD.
2 Dec 2008 - Cortisol suppression as a surrogate marker for inhaled corticosteroid-induced growth retardation in children.
3 Nov 2008 - Risk assessment of aflatoxins in food in Africa.
29 Sep 2008 - Permanent reduction of mandibular size and bone stiffness induced in post-weaning rats by cyclophosphamide.
22 Sep 2008 - Long-term safety of stimulant medications used to treat children with ADHD.
30 Jul 2008 - Clinical inquiries. Is there much risk in using fluoroquinolones in children?
30 Jul 2008 - [hrGH treatment of glucocorticoid-induced short stature in children]
29 Jun 2008 - Postreceptor crosstalk on PI3K/Akt between GH and insulin in non-catch-up growth rats born small for gestational age.
19 May 2008 - Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.
30 Dec 2007 - Adult height of three renal transplant patients after growth hormone therapy.
19 Dec 2007 - Impact of nutrition on phenotype in CFTR-deficient mice.
30 Oct 2007 - Association of Harris lines and shorter stature with ethanol consumption during growth.
27 Oct 2007 - Proteasome inhibition up-regulates p53 and apoptosis-inducing factor in chondrocytes causing severe growth retardation in mice.
13 Oct 2007 - Balanced calcitriol treatment to make children grow.
30 Aug 2007 - The administration of oleoyl-estrone to lactating dams induces selective changes in the normal growth pattern of their pups.
30 Jul 2007 - A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
30 Jul 2007 - Minimizing side effects of systemic corticosteroids in children.
29 Jun 2007 - Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus.
19 Jun 2007
See a longer list of these articles.
Technical information about 'Growth Disorders'
Definition: Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth.
Descriptor UI: D006130
Alternative terms: Growth Disorders; Disorder, Growth; Growth Disorder;
Related Mesh Headings: Bone Diseases, Developmental; Dwarfism; Gigantism;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;
Tree Number: C23.550.393;
History Note: 72(69)
Technical Notes: do not confuse with NUTRITION DISORDERS (disord of assimilating & utilizing nutrients)